T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein

Emily K. Forbes(University of Oxford), Simon J. Draper(University of Oxford), Anna L. Goodman(St Thomas' Hospital), Carole A. Long(National Institutes of Health), Adrian V. S. Hill(Jenner Institute), Sumi Biswas(University of Oxford), F. Hill(Imaxio (France)), David Llewellyn(University of Oxford), Richard J. Pleass(Liverpool School of Tropical Medicine), Matthew G. Cottingham(University of Oxford), Simone C. de Cassan(University of Oxford)
PLoS ONE
September 12, 2012
10.1371/journal.pone.0044943
Cited by 25

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
|The Lancet|2001|528